News

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
The injectable HIV prevention treatment Yetzugo, made by Gilead Sciences, has received FDA approval, offering a twice-yearly ...
Christian music artist Amy Grant performs to support PEPFAR, the global HIV/AIDS initiative facing budget cuts after saving ...
FDA approves Yeztugo HIV prevention injection showing 96% efficacy in clinical trials, but $14,000 cost creates significant access barriers for patients.
The U.S. Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV. (Scripps News) ...
Tripura Chief Minister Prof. Dr. Manik Saha on Thursday announced that the state government is considering introducing ...